Melanie Welham
Dame Melanie Joanne Welham (born 1964) DBE is a British biochemist who was Executive Chair of the Biotechnology and Biological Sciences Research Council from April 2018 to June 2023. She was previously a professor of biochemistry at the University of Bath, where she worked on stem cell biology.
Melanie Welham | |
|---|---|
Welham as BBSRC Chief Executive in 2018 | |
| Born | Melanie Joanne Welham 1964 (age 59–60) |
| Alma mater | Imperial College London University College London |
| Scientific career | |
| Institutions | University of British Columbia Biotechnology and Biological Sciences Research Council University of Bath |
| Thesis | Functional and genetic analyses of the V-"src" oncogene (1988) |
Early life and education edit
Welham was born and raised in Suffolk. Her father worked in agriculture, and she was the first member of her family to attend university. She studied biochemistry at Imperial College London, where only 15% of undergraduate students were women.[1] She moved to University College London for doctoral research, where she studied the oncogene.[2] She then moved to the University of British Columbia, where she worked as a postdoctoral researcher.[1]
Research and career edit
Welham joined the University of Bath as a lecturer[when?], where she worked on molecular signalling and stem cell science. She was the first woman to be promoted to Professor at Bath.[3]
Welham joined Biotechnology and Biological Sciences Research Council (BBSRC) on secondment in 2012.[4] In 2018 Welham was made Executive Chair of BBSRC, two years prior to this, she served as Interim Chief Executive of the Council.[4][5]
She is committed to diversity and inclusion, and serves as Executive Champion for People, Culture and Talent at UK Research and Innovation.[4][6] She was made a trustee of the Royal Society of Biology in 2023.[7]
She was awarded a DBE for services to the biosciences in the 2023 Birthday Honours.
Selected publications edit
- Bart Vanhaesebroeck; Melanie J. Welham; Kei Kotani; et al. (29 April 1997). "p110δ, a novel phosphoinositide 3-kinase in leukocytes". Proceedings of the National Academy of Sciences of the United States of America. 94 (9): 4330–5. Bibcode:1997PNAS...94.4330V. doi:10.1073/PNAS.94.9.4330. ISSN 0027-8424. PMC 20722. PMID 9113989. Wikidata Q24314825.
- Nicholas R.D. Paling; Helen Wheadon; Heather K. Bone; Melanie J. Welham (24 August 2004). "Regulation of embryonic stem cell self-renewal by phosphoinositide 3-kinase-dependent signaling". Journal of Biological Chemistry. 279 (46): 48063–48070. doi:10.1074/JBC.M406467200. ISSN 0021-9258. PMID 15328362. Wikidata Q40522498.
- Karen Wright; Nicholas Rooney; Mark Feeney; Jeremy Tate; Duncan Robertson; Melanie Welham; Stephen Ward (1 August 2005). "Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing". Gastroenterology. 129 (2): 437–453. doi:10.1053/J.GASTRO.2005.05.026. ISSN 0016-5085. PMID 16083701. Wikidata Q34440704.
References edit
- ^ a b Give Me Inspiration! The Paradigm Shift with Professor Melanie Welham, retrieved 22 June 2023
- ^ "Functional and genetic analyses of the V-"src" oncogene | WorldCat.org". worldcat.org. Retrieved 22 June 2023.
- ^ "Melanie Welham". The Physiological Society. Retrieved 22 June 2023.
- ^ a b c "Professor Dame Melanie Welham". www.ukri.org. Retrieved 22 June 2023.
- ^ "Professor Melanie Welham selected for the role of Executive Chair of the Biotechnology and Biological Sciences Research Council". GOV.UK. Retrieved 22 June 2023.
- ^ "Finding for the Modern Copernicus Today - Talk and Panel Discussion - Poland in the UK - Gov.pl website". Poland in the UK. Retrieved 22 June 2023.
- ^ "Executive Chair of BBSRC, UKRI, appointed as RSB Trustee". RSB. Retrieved 22 June 2023.